Abstract
The GM2 activator protein is an essential component for the degradation of GM2 ganglioside by hexosaminidase A in vivo. Mutations in the human gene coding for the GM2 activator protein cause the AB variant of GM2-gangliosidosis, a condition that is clinically indistinguishable from Tay-Sachs disease. To understand better factors affecting the expression of the GM2 activator protein gene (Gm2a) in mouse tissues, we have determined its exon-intron organization and analyzed its promoter region.Gm2a is about 14 kb, has four exons, and the 5′ flanking region contains a CAAT box, Spl binding sites, AP-1, AP-2 sites, and a pair of IRE sites. A 1.2-kb fragment upstream from the initiation codon was shown to have promoter activity in NIH 3T3 cells. Similarities between the elements present in Gm2a and Hexa promoters might in part explain their similar expression patterns in mouse tissues. The different levels of GM2 activator protein mRNA in liver, kidney, brain, and testis are not owing to the use of different transcription start sites, because a single start site was found 50 bp upstream from the initiation codon in each these tissues. Northern blot analysis demonstrated variation in the GM2 activator protein mRNA expression during mouse development. Gm2a was mapped to Chromosome (Chr) 11, where it co-segregated with Csfgm.
This is a preview of subscription content, log in via an institution to check access.
Similar content being viewed by others
References
Beccari T, Palmerini CA, Servillo G, Delia Fazia MA, Viola-Magni MP, Orlacchio A (1994). GM2 activator protein expression in mouse tissues. Biochem Biophys Res Commun 204, 741–745
Bellachioma G, Stirling JL, Orlacchio A, Beccari T (1993). Cloning and sequence analysis of a cDNA clone coding for the mouse GM2 activator protein. Biochem J 294, 227–230
Birkenmeier EH, Rowe LB, Crossman MW, Gordon JI (1994). Illeal lipid-binding protein (ILLBP) gene maps to mouse chromosome-11. Mamm Genome 5, 805–806
Breathnach R, Chambon P (1981). Organization and expression of eukaryotic split genes coding for proteins. Annu Rev Biochem 50, 349–383
Burg J, Banerjee B, Conzelmann E, Sandhoff K (1983). Activating proteins for ganglioside GM2 degradation by β-hexosaminidase isoenzymes in tissue extracts from different species. Hoppe-Seyler’s Z. Physiol Chem 364, 821–829
Burg J, Conzelmann E, Sandhoff K, Solomon E, Swallow DM (1985). Mapping of the gene coding for the human GM2 activator protein to chromosome-5. Ann Hum Genet 49, 41–45
Cohen-Tannoudji M, Marchand P, Akli S, Sheardown SA, Puech JP, Kress C, Gressens P, Nassogne MC, Beccari T, Muggleton-Harris AL, Evrard P, Stirling JL, Poenaru L, Babinet C (1995). Disruption of murine Hexa gene leads to enzymatic deficiency and to neuronal lysosomal storage, similar to that observed in Tay-Sachs disease. Mamm Genome 6, 844–849
Furst W, Sandhoff K (1992) Activator proteins and topology of lysosomal sphingolipid catabolism. Biochim Biophys Acta 1126, 1–16
Klima H, Tanaka A, Schnabel D, Nakano T, Schroder M, Suzuki K, Sandhoff K (1991). Characterization of full length cDNAs and the gene coding for the human GM2 activator protein. FEBS Lett 289, 260–264
Kuwana T, Mullock BM, Luzio JP (1995). Identification of a lysosomal protein causing lipid transfer, using a fluorescence assay designed to monitor membrane fusion between rat liver endosomes and lysosomes. Biochem J 308, 937–946
Nagarajian S, Chen HC, Li SC, Li YT, Lockyer JM (1992). Evidence for two cDNA clones encoding human GM2 activator protein. Biochem J 282, 807–813
Nasrin N, Ercolani L, Denard M, Kong XF, Kang I, Alexander M (1990). Insulin stimulates glyceraldehyde-3-phosphate dehydrogenase gene expression through cis-acting DNA sequences. Proc Natl Acad Sci USA 87, 5273–5277
Phaneuf D, Wakamatsu N, Huang JQ, Borowski A, Peterson AC, Fortunato SR, Ritter G, Igdoura SA, Morales CR, Benoit G, Akerman BR, Leclerc D, Hanai N, Marth JD, Trasler JM, Gravel RA (1996) Dramatically different phenotypes in mouse models of human Tay-Sachs and Sandhoff diseases. Hum Mol Genet 5, 1–14
Rowe LB, Nadeau JH, Turner R, Frankel WN, Letts VA, Eppig JT, Ko MSH, Thurston SJ, Birkenmeier EH (1994). Maps from 2 interspecific backcross DNA panels available as a community genetic-mapping resource. Mamm Genome 5, 253–274
Sambrook J, Fritsch FF, Maniatis T (1989). Molecular Cloning: A Laboratory Manual, 2nd ed. (Cold Spring Harbor, N.Y.: Cold Spring Harbor Laboratory Press)
Sandhoff K, Conzelmann E, Neufeld EF, Kaback MM, Suzuki K (1989). The GM2 gangliosidoses. In The Metabolic Basis of Inherited Diseases, 6th ed. CR Scriver, AL Beaudet, WS Sly, D Valle, eds. (New York: McGraw-Hill), pp. 1807–1839
Sanger F, Nicklen S, Coulson AR (1977). DNA sequencing with chain-terminating inhibitors. Proc Natl Acad Sci USA 74, 5463–5467
Sango K, Yamanaka S, Hoffmann A, Okuda Y, Grinberg A, Westphal H, McDonald MP, Crawley JN, Sandhoff K, Suzuki K, Proia RL (1995) Mouse models of Tay-Sachs and Sandhoff diseases differ in neurologic phenotype and ganglioside metabolism. Nature Genet 11, 170–176
Schroder M, Klima H, Nakano T, Kwan H, Quintern LE, Gartner S, Suzuki K, Sandhoff K (1989). Isolation of a cDNA encoding the human GM2 activator protein. FEBS Lett 251, 197–200
Xie B, McInnes B, Neote K, Lamhonwah AM, Mahuran D (1991). Isolation and expression of a full-length cDNA encoding the human GM2 activator protein. Biochem Biophys Res Commun 177, 1217–1223
Xie B, Kennedy JL, Mclnnes B, Auger D, Mahuran D (1992). Identification of a processed pseudogene related to the functional gene and encoding the GM2 activator protein: localization of the pseudogene to human chromosome 3 and the functional gene to human chromosome 5. Genomics 14, 796–798
Yamanaka S, Johnson ON, Norflus F, Boles DJ, Proia RL (1994a). Structure and expression of the mouse β-hexosaminidase genes, Hexa and Hexb. Genomics 21, 588–596
Yamanaka S, Johnson MD, Grinberg A, Westphal H, Crawley JN, Taniike M, Suzuki K, Proia RL (1994b). Targeted disruption of the Hexa gene results in mice with biochemical and pathologic features of Tay-Sachs disease. Proc Natl Acad Sci USA 91, 9975–9979
Yamanaka S, Johnson ON, Lyu MS, Kozak CA, Proia RL (1995). The mouse gene encoding the GM2 activator protein (Gm2a): cDNA sequence, expression, and chromosome mapping. Genomics 24, 601–604
Author information
Authors and Affiliations
Additional information
The nucleotide sequences reported in this paper have been submitted to Genbank and have been assigned the following Accession Numbers: 5′ flanking region and Exon 1, U34356 (Banklt 11744): Exon 2, U34357 (Banklt 12601): Exon 3, U34358 (Banklt 12634); Exon 4, U34359 (Banklt 12635). MGD accession number: MGD- CREX- 362
Rights and permissions
About this article
Cite this article
Bertoni, C., Appolloni, M.G., Stirling, J.L. et al. Structural organization and expression of the gene for the mouse GM2 activator protein. Mammalian Genome 8, 90–93 (1997). https://doi.org/10.1007/s003359900364
Received:
Accepted:
Issue Date:
DOI: https://doi.org/10.1007/s003359900364